Loading...
10 Middle East and Africa Anticoagulants Reports
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Johnson & Johnson, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc., Johnson & Johnson, Baxter, Shanghai RAAS blood products co., Ltd, General Electric Company (GE Healthcare)
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Ltd, GSK plc, Viatris, Inc., Jiangsu Hengrui Pharmaceuticals Co., Ltd
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Octapharma AG, LFB USA, Takeda Pharmaceutical Company Limited, Grifols, S.A, CSL
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Portola Pharmaceuticals Inc, Pfizer Inc, Octapharma AG, CSL Behring Limited, Boehringer Ingelheim Pharma GmbH
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Opocrin SpA, Baxter International, Aspen Pharmacare Holdings Limited, B Braun Melsungen AG, Pfizer Inc.
Region Covered: Middle East and Africa
Study Period: 2020 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Aspen Holdings, Boehringer Ingelheim International GmbH
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc., Bayer AG , Boehringer Ingelheim International GmbH, Johnson & Johnson, Pfizer Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Aspen Holdings, Changzhou Qianhong Bio-Pharma, B. Braun Medical, Inc., Pfizer, Inc., Dr. Reddy's Laboratories Limited
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Mitsubishi Tanabe Pharma Corporation, AuroMedics Pharma LLC, Pfizer Inc, Viatris Inc, Hikma Pharmaceuticals PLC
Filter Reports
By Countries
